GB0621438D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0621438D0
GB0621438D0 GB0621438A GB0621438A GB0621438D0 GB 0621438 D0 GB0621438 D0 GB 0621438D0 GB 0621438 A GB0621438 A GB 0621438A GB 0621438 A GB0621438 A GB 0621438A GB 0621438 D0 GB0621438 D0 GB 0621438D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0621438A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0621438A priority Critical patent/GB0621438D0/en
Publication of GB0621438D0 publication Critical patent/GB0621438D0/en
Priority to ARP070101101A priority patent/AR059961A1/en
Priority to EA200802007A priority patent/EA200802007A1/en
Priority to AU2007228778A priority patent/AU2007228778A1/en
Priority to KR1020087025484A priority patent/KR20090005003A/en
Priority to CA002646585A priority patent/CA2646585A1/en
Priority to BRPI0710070-1A priority patent/BRPI0710070A2/en
Priority to PCT/EP2007/052568 priority patent/WO2007107539A1/en
Priority to EP07727046A priority patent/EP1996555A1/en
Priority to US11/687,729 priority patent/US7566735B2/en
Priority to TW096109252A priority patent/TW200812975A/en
Priority to JP2009500838A priority patent/JP2009531320A/en
Priority to MX2008012054A priority patent/MX2008012054A/en
Priority to PE2007000291A priority patent/PE20071156A1/en
Priority to NO20084049A priority patent/NO20084049L/en
Priority to MA31271A priority patent/MA30325B1/en
Priority to US12/326,176 priority patent/US7642256B2/en
Ceased legal-status Critical Current

Links

GB0621438A 2006-03-20 2006-10-27 Compounds Ceased GB0621438D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GB0621438A GB0621438D0 (en) 2006-10-27 2006-10-27 Compounds
PE2007000291A PE20071156A1 (en) 2006-03-20 2007-03-19 COMPOUNDS DERIVED FROM 4,5,6,7-TETRAHYDRO-1H-INDAZOLE AS ENHANCERS OF THE a-AMINO-3-HYDROXY-5-METHYLISOXAZOLE-4-PROPIONIC ACID RECEPTOR (AMPA)
EP07727046A EP1996555A1 (en) 2006-03-20 2007-03-19 Compounds which potentiate ampa receptor and uses thereof in medicine
TW096109252A TW200812975A (en) 2006-03-20 2007-03-19 Compounds which potentiate AMPA receptor and uses thereof in medicine
AU2007228778A AU2007228778A1 (en) 2006-03-20 2007-03-19 Compounds which potentiate AMPA receptor and uses thereof in medicine
KR1020087025484A KR20090005003A (en) 2006-03-20 2007-03-19 Compounds which potentiate ampa receptor and uses thereof in medicine
CA002646585A CA2646585A1 (en) 2006-03-20 2007-03-19 Compounds which potentiate ampa receptor and uses thereof in medicine
BRPI0710070-1A BRPI0710070A2 (en) 2006-03-20 2007-03-19 compounds that potentiate the amp receptor and their uses in medicine
PCT/EP2007/052568 WO2007107539A1 (en) 2006-03-20 2007-03-19 Compounds which potentiate ampa receptor and uses thereof in medicine
ARP070101101A AR059961A1 (en) 2006-03-20 2007-03-19 COMPOUND DERIVED FROM PHENYL TETRAHYDRO-INDAZOL, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE IT, USES TO PREPARE A MEDICINAL PRODUCT FOR THE TREATMENT OF AN ILLNESS THROUGH A REDUCTION OR UNBALANCE IN THE FUNCTION OF THE GLUTAMATE RECEIVER AND PROCESSES FOR SUITABILITY
US11/687,729 US7566735B2 (en) 2006-03-20 2007-03-19 Compounds which potentiate AMPA receptor and uses thereof in medicine
EA200802007A EA200802007A1 (en) 2006-03-20 2007-03-19 COMPOUNDS POTENTIATING AMPA RECEPTOR AND APPLICATION OF THE SPECIFIED COMPOUNDS IN MEDICINE
JP2009500838A JP2009531320A (en) 2006-03-20 2007-03-19 Compounds that potentiate AMPA receptors and their use in medicine
MX2008012054A MX2008012054A (en) 2006-03-20 2007-03-19 Compounds which potentiate ampa receptor and uses thereof in medicine.
NO20084049A NO20084049L (en) 2006-03-20 2008-09-23 Compounds with enhanced ampa receptor and its use in medicine
MA31271A MA30325B1 (en) 2006-03-20 2008-10-07 COMPOUNDS THAT POTENTIATE THE AMPA RECEPTOR AND THEIR USES IN MEDICINE
US12/326,176 US7642256B2 (en) 2006-03-20 2008-12-02 Compounds which potentiate AMPA receptor and uses thereof in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0621438A GB0621438D0 (en) 2006-10-27 2006-10-27 Compounds

Publications (1)

Publication Number Publication Date
GB0621438D0 true GB0621438D0 (en) 2006-12-06

Family

ID=37546112

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0621438A Ceased GB0621438D0 (en) 2006-03-20 2006-10-27 Compounds

Country Status (1)

Country Link
GB (1) GB0621438D0 (en)

Similar Documents

Publication Publication Date Title
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
GB0606876D0 (en) Compounds
GB0605786D0 (en) Compounds
EP1984379A4 (en) Anti-arenaviral compounds
GB0607175D0 (en) Compounds
GB0605785D0 (en) Compounds
GB0605784D0 (en) Compounds
EP2082022A4 (en) Compounds
GB0606913D0 (en) Compounds
EP2004174A4 (en) Naphthalenedione compounds
GB0602042D0 (en) Compounds
EP1973905A4 (en) Compounds
EP2016069A4 (en) Bis-pyridinium compounds
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0603132D0 (en) Compounds
GB0621438D0 (en) Compounds
GB0605410D0 (en) Compounds
GB0602451D0 (en) Compounds
GB0604375D0 (en) Compounds
GB0603551D0 (en) Compounds
GB0603133D0 (en) Compounds
GB0605588D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)